[Piracetam and the activity of alpha- and beta-adrenergic, dopaminergic and muscarine cholinergic receptors (author's transl)].
D000818:Animals; D004285:Dogs; D005263:Femoral Artery / Q000502:physiology; D066298:In Vitro Techniques; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular / Q000502:physiology; D009200:Myocardial Contraction; D010889:Piracetam / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000502:physiology*; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D011950:Receptors, Cholinergic / Q000502:physiology*; D011954:Receptors, Dopamine / Q000502:physiology*; D011976:Receptors, Muscarinic / Q000502:physiology*; D012039:Regional Blood Flow / Q000187:drug effects
D011760:Pyrrolidinones; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D011976:Receptors, Muscarinic; D010889:Piracetam
Piracetam i aktivnost alpha i beta-adrenergickih, dopaminskih i muskarinskih receptora.